CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects

Biological Psychiatry

Volumn 45, Issue 12, 1999, Pages 1572-1579

  Cremniter, Didier ^a   Jamain, Sylvie ^a   Kollenbach, Kaï ^b   Alvarez, Jean Claude ^b   Lecrubier, Yves ^c   Gilton, Alain ^a   Jullien, Philippe ^b   Lesieur, Philippe ^d   Bonnet, Francis ^a   Spreux Varoquaux, Odile ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Centre Philippe Paumelle   (France)

Author keywords

CSF 5 HIAA; CSF HVA; Impulsivity; Violent suicide attempt

Indexed keywords

5 HYDROXYINDOLEACETIC ACID;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; IMPULSIVENESS; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SUICIDE ATTEMPT; VIOLENCE;

EID: 0033564815     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00382-5     Document Type: Article

References (59)

1. Agren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid. II. Suicide. Psychiatr Res. 3:1980;225-236.
2. Agren H., Mefford I., Rudorfer M., Linnoila M., Potter W. Interacting neurotransmitter system A nonexperimental approach to the 5-HIAA-HVA correlation in human CSF . J Psychiatry Res. 20:1986;175-193.
3. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. 1986;American Psychiatric Press, Washington, DC.
4. Asberg M. Monoamine neurotransmitters in human aggressiveness and violence A selective review . Crimin Behav Ment Health. 4:1994;303-327.
5. Asberg M., Bertilsson L., Martensson B., Scalia-Tomba G.P., Thoren P., Träskman-Benz L. CSF monoamine metabolites in melancholia . Acta Psychiatr Scand. 69:1984;201-219.
6. Asberg M., Bertilsson L., Thoren P. CSF monoamine metabolites in depressive illness. Garattini S. Depressive Disorders. 1978;293-305 Verlag, New York.
7. Asberg M., Träskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 33:1976;1193-1197.
8. Banki C., Arato M., Papp Z., Kurcz M. Biochemical markers in suicidal patients Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests . J Aff Disord. 6:1984;341-350.
9. Banki C., Molnar G. The influence of age, height and body weight on CSF amine metabolites and tryptophan in women. Biol Psychiatry. 16:1981;753-762.
10. Bowers M., Gerbode F. The relationship of monoamine metabolites in human CSF to age. Nature. 219:1968;1256-1257.
11. Brown G., Ebert M., Goyer P.F., et al. Aggression, suicide and serotonin. Relationships to amine CSF metabolites. Am J Psychiatry. 139:1982;741-746.
12. Brown G., Goodwin F.K., Ballenger J.C., Goyer P.F., Major L.F. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:1979;131-139.
13. Coccaro E.F., Siever L., Klar H., et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 46:1989;587-599.
14. Diekstra K.F.W. The epidemiology of suicide and parasuicide. Acta Psychiatr Scand Suppl. 37:1993;9-20.
15. Faull K.F., King R.J., Berger P.A., Barchas J.D. Systems theory as a tool for functional interactions among biogenic amines. Usdim E., Carlsson A., Dahlstrom A., Engel J. Catecholamines Neuropharmacology and Central Nervous System. Therapeutic Aspects . 1984;143-152 Alan R. Liss, New York.
16. Faustman W.O., King R.J., Faull K.F., et al. MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia. J Aff Disord. 22:1991;235-239.
17. Faustman W.O., Ringo D.L., Faull K.F. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Br J Psychiatry. 163:1993;519-521.
18. Galva M.D., Bondiolotti G.P., Olasmaa M., Picotti G.B. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. J Neural Transm Gen Sect. 101:1995;83-94.
19. Gattaz W.F., Waldmeier P., Beckmann H. Cerebrospinal fluid monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 66:1982;350-360.
20. Gerner R.H., Fairbanks L., Anderson G.M., et al. CSF neurochemistry in depressed, manic and schizophrenic patients compared with that of normal controls. Am J Psychiatry. 141:1984;1533-1540.
21. Gjerris A., Sorensen A., Rafaelsen O., Werdelin L., Alling C., Linnoila M. 5HT and 5-HIAA in cerebrospinal fluid in depression. J Aff Disord. 12:1987;13-22.
22. Gottfries C.G., Gottfries I., Johansson B. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology. 10:1971;665-672.
23. Hamilton M (1969): Diagnosis and rating of anxiety. In: Lader MH, editor. Studies of Anxiety. Br J Psychiatry, Spec.Pub 3:76-79.
24. Jibson M., Faull K.F., Csernansky J.G. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system. Biol Psychiatry. 28:1990;595-602.
25. Koslow S.H., Maas J.W., Bowden C.L., Davis J.M., Hanin I., Javaid J. Cerebrospinal fluid and urinary biogenic amines and metabolites in depression and mania. Arch Gen Psychiatry. 40:1983;999-1010.
26. Lecrubier Y., Braconnier A., Said S., Payan C. The impulsivity rating scale (IRS) preliminary results. Eur Psychiatry. 10:1995;331-338.
27. Lidberg L., Tuck J.R., Asberg M., Scalia-Tomba G., Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand. 71:1985;230-236.
28. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sci. 33:1983;2609-2614.
29. Maas J.W., Kocsis J.H., Bowden C.L., et al. Preatreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med. 12:1982;37-43.
30. Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed in patients. Biol Psychiatry. 41:1997;162-171.
31. Montgomery S., Montgomery D. Pharmacological prevention of suicidal behaviour. J Aff Disord. 4:1982;291-298.
32. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:1979;383-389.
33. Ninan P., Van Kammen D., Scheinin M., Linnoila M., Bunney W., Goodwin F. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry. 141:1984;566-569.
34. Nordström P., Samuelsson M., Asberg M., et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav. 24:1994;1-9.
35. Oreland L., Wiberg A., Asberg M., et al. Platelet MAO activity and monoamine metabolites in CSF in depressed and suicidal patients and healthy controls. Psychiatry Res. 4:1981;21-29.
36. Papeschi R., McLure D. HVA and 5HIAA in CSF of depressed patients. Arch Gen Psychiatry. 25:1971;354-358.
37. Post R.M., Goodwin F.K. Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients. Arch Gen Psychiatry. 36:1974;234-239.
38. Risby E.D., Hsaio J., Sunderland T., Agren H., Rudorfer M.V., Potter W.Z. The effects of antidepressants and the cerebrospinal fluid homovanillic acid/ 5-hydroxyindoleacetic acid ratio. Clin Pharmacol Ther. 42:1987;547-554.
39. Rosen D.H. The serious suicide attempt. Five year follow-up study of 886 patients. JAMA. 235:1976;2105-2109.
40. Roy A., Agren H., Pickar D., Linnoila M., Doran A.R., Paul S. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients Relationship to suicidal behaviour and dexamethasone nonsuppression . Am J Psychiatry. 143:1986;1539-1545.
41. Roy A., De Jong J., Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behaviour in depressed patients. Arch Gen Psychiatry. 46:1989;609-612.
42. Roy A., Linnoila M. Suicidal behaviour, impulsiveness and serotonin. Acta Psychiatr Scand. 78:1988;529-535.
43. Rydin E., Schalling D., Asberg M. Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Psychiatry Res. 7:1982;229-243.
44. Sarrias M.J., Cabre P., Martinez E., Artigas F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem. 54:1990;783-786.
45. Saura J., Andrés N., Andrade C., Ojuel J., Eriksson K., Mahy N. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging. 18:1997;497-507.
46. Sedvall G., Fyro B., Gullberg B., Nyback H., Wiesel F.A., Wode-Helgadt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry. 136:1980;366-374.
47. Träskman-Bendz L., Alling C., Alsen M., Regnell G., Simonsson P., Ohman R. The role of monoamines in suicidal behaviour. Acta Psych Scand. 371 suppl:1993;45-47.
48. Träskman-Bendz L., Alling C., Greland L., Regnell G., Vinge E., Ohman R. Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol. 12 suppl 2:1992;219-226.
49. Träskman-Bendz L., Asberg M., Bertilsson L., Sjostrand L. Monoamine metabolites in CSF and suicidal behaviour. Arch Gen Psychiatry. 38:1981;631-636.
50. Van Praag H.M. Serotonergic dysfunction and aggression control. Psychol Med. 21:1991;15-19.
51. Van Praag H.M. Serotonergic mechanisms and suicidal behaviour. Psychiatry Psychobiol. 3:1988;335-346.
52. Van Praag H.M. (Auto-)aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacol Bull. 22:1986;669-673.
53. Van Praag H.M. Depression, suicide and the metabolism of serotonin in brain. J Aff Disord. 4:1982;275-290.
54. Van Praag H.M., Kahn R.S., Asnis G.M., et al. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord. 13:1987;1-8.
55. Van Praag H.M., Plutchik R. An empirical study on the "cathartic effect" of attempted suicide. Psychiatry Res. 16:1985;123-130.
56. Virkkunen M., De Jong J., Bartko J., Goodwin F., Linnoila M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. Arch Gen Psychiatry. 46:1989;600-603.
57. Virkkunen M., De Jong J., Bartko J., Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch Gen Psychiatry. 46:1989;604-606.
58. Westergaard P., Sörensen T., Hoppe E., Rafaeelsen O.S., Yates C.M., Nicalaoiu N. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand. 58:1978;88-96.
59. Weyler W., Hsu Y.P., Breakefield X.O. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther. 47:1990;391-417.